Come join us for a fascinating panel discussion on the critical role of integration and aftercare in psychedelic trials, featuring former psilocybin and DMT trial participants Leonie Schneider and Ian Roullier, alongside former MDMA therapy participant Pedram Dara. Our panelists will provide valuable first-hand insights into their experiences undergoing psychedelic therapy as trial participants, discussing the often-overlooked issue of inadequate integration and aftercare support and exploring potential solutions to improve the process.

Beyond sharing their personal experiences, the panelists will delve into the profound psychological and emotional effects of psychedelic therapies and how these experiences have impacted their lives. This event promises to be of great interest to researchers, mental health professionals, and anyone keen to learn more about the rapidly evolving field of psychedelic therapy, particularly in the context of clinical trials.